Balyasny Asset Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLRB
Balyasny Asset Management's CLRB Position: Q3 2026 in Review
Balyasny Asset Management held its Cellectar Biosciences (CLRB) position steady in Q3 2026 at 220,000 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #2641.
Balyasny Asset Management first reported a position in CLRB in Q2 2026 and has held it in 2 quarters since. The position peaked at $612K in Q2 2026. 28 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.
- Balyasny Asset Management held 220,000 shares of Cellectar Biosciences worth $405K as of Q3 2026.
- Balyasny Asset Management left its Cellectar Biosciences share count unchanged in Q3 2026.
- Cellectar Biosciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #2641 holding.
- Balyasny Asset Management first reported a position in Cellectar Biosciences in Q2 2026 and has held it in 2 quarters since.
- Balyasny Asset Management's Cellectar Biosciences position peaked at $612K in Q2 2026.
- 28 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.